Evidence map›Paper›PMID 29184795›Full record

ReviewTranslational andrology and urology2017

Amniotic therapeutic biomaterials in urology: current and future applications.

Siam Oottamasathien, James M Hotaling, James R Craig, Jeremy B Myers, William O Brant

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Translational andrology and urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Editorial Comment.Indian journal of urology : IJU : journal of the Urological Society of India
    Article
  13. Low-dose prednisone is an effective rescue for deteriorating semen parameters following vasovasostomy.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Siam OottamasathienDepartment of Surgery and Section of Pediatric Urology, University of Utah, Salt Lake City, Utah, USA.
James M HotalingDepartment of Surgery and Section of Pediatric Urology, University of Utah, Salt Lake City, Utah, USA.
James R CraigDepartment of Surgery and Section of Pediatric Urology, University of Utah, Salt Lake City, Utah, USA.
Jeremy B MyersDepartment of Surgery and Section of Pediatric Urology, University of Utah, Salt Lake City, Utah, USA.
William O BrantDepartment of Surgery and Section of Pediatric Urology, University of Utah, Salt Lake City, Utah, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To examine the rationale and applications of amniotic tissue augmentation in urological surgery. Published literature in English-language was reviewed for basic science and clinical use of amniotic or amnion-chorionic tissue in genitourinary tissues. Basic science and animal studies support the likely benefit of clinical applications of amnion-derived tissues in a variety of urologic interventions. The broad number of properties found in amniotic membrane, coupled with its immunologically privileged status presents a number of future applications in the urological surgical realm. These applications are in their clinical infancy and suggest that further studies are warranted to investigate the use of these products in a systematic fashion.

Indexed as

Amnionchoriondehydrated membraneshypospadiasurethral reconstruction

Identifiers

PMID29184795
PMCPMC5673810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.